Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | C3AR1 | Q16581 | 2/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | NPY2R | P49146 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6794052 | 1.00 | GNPAT (0.47) | GNPATC3AR1NOD1FOLH1SLC6A5 | |
| SCHEMBL31751570 | 0.92 | C3AR1 (0.43) | GNPATC3AR1NOD1FOLH1SLC6A5 | |
| SCHEMBL12971400 | 0.92 | SLC6A5 (0.53) | GNPATNOD1FOLH1SLC6A5EPHX2 | |
| SCHEMBL12971402 | 0.92 | SLC6A5 (0.53) | GNPATNOD1FOLH1SLC6A5EPHX2 | |
| SCHEMBL17304346 | 0.90 | SLC6A5 (0.55) | GNPATNOD1FOLH1SLC6A5NPY1R | |
| SCHEMBL17304351 | 0.90 | SLC6A5 (0.55) | GNPATNOD1FOLH1SLC6A5NPY1R | |
| SCHEMBL12971327 | 0.90 | SLC6A5 (0.55) | GNPATNOD1FOLH1SLC6A5NPY1R | |
| SCHEMBL12971329 | 0.90 | SLC6A5 (0.55) | GNPATNOD1FOLH1SLC6A5NPY1R | |
| SCHEMBL7275349 | 0.90 | SLC6A5 (0.55) | GNPATNOD1FOLH1SLC6A5NPY1R | |
| SCHEMBL8741237 | 0.88 | GNPAT (0.50) | GNPATC3AR1NOD1FOLH1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118837461-A | Biomarker for identifying acute stage and intermittent stage of gout and application thereof | 查理高特(青岛)健康科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118243924-A | Serum metabolic marker for diagnosing or monitoring bladder cancer and application thereof | 宁夏医科大学总医院 | 2024-06-25 | — | — | CN | claimed |
| CN-117007703-A | Diagnostic marker for urinary calculus, diagnostic kit and application thereof | 中国人民解放军海军军医大学第一附属医院 | 2023-11-07 | — | — | CN | claimed |
| US-20030083380-A1 | Method of using hydroxycarboxylic acids or related compounds for treating skin changes asociated with intrinsic and extrinsic aging | YU RUEY J (US) | 2003-05-01 | — | — | US | claimed |
| US-5702688-A | TREATING SKIN DISORDERS | TRISTRATA TECHNOLOGY, INC. (US) | 1997-12-30 | — | — | US | claimed |
| US-5690967-A | MIXTURE CONTAINING AMPHOTERIC AGENT | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-25 | — | — | US | claimed |
| US-5684044-A | MIXED WITH AMPHOTERIC OR PSEUDOAMPHOTERIC AGENT | TRISTRATA, INCORPORATED (US) | 1997-11-04 | — | — | US | claimed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | claimed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | claimed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | disclosed |
| CN-119156444-A | Microorganism having enhanced aspartic acid 1-decarboxylase activity derived from orychophragmus violaceus and use thereof | CJ第一制糖株式会社 | 2024-12-17 | — | — | CN | disclosed |
| CN-119095958-A | Variants of aspartate 1-decarboxylase derived from orychophragmus violaceus and microorganisms comprising the same | CJ第一制糖株式会社 | 2024-12-06 | — | — | CN | disclosed |
| CN-118837461-A | Biomarker for identifying acute stage and intermittent stage of gout and application thereof | 查理高特(青岛)健康科技有限公司 | 2024-10-25 | — | — | CN | disclosed |
| CN-118243924-A | Serum metabolic marker for diagnosing or monitoring bladder cancer and application thereof | 宁夏医科大学总医院 | 2024-06-25 | — | — | CN | disclosed |
| EP-0413528-B1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | YU RUEY J (US) | 1995-11-15 | — | — | EP | disclosed |
| EP-0671162-A2 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1995-09-13 | — | — | EP | disclosed |
| US-5385938-A | application of mixtures containing hydroxyacetic acid(or its salts) to skin | IGI, INC. | 1995-01-31 | — | — | US | disclosed |
| US-5091171-A | Skin disorders | IGI, INC. | 1992-02-25 | — | — | US | disclosed |
| EP-0413528-A1 | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | Yu, Ruey J., Dr. (US) | 1991-02-20 | — | — | EP | disclosed |